text, sign
http://www.youtube.com/channel/UCrp_UI8XtuYfpiqluWLD7Lw,CNBC Television
Video reading area

Origin Ten Technology is driven by a desire to make the world a better place.

This area has been designed to improve Video accessibility for user with hearing problems and for those who just prefer to read.

December 9, 2021By Origin Ten LTD7 Minutes

Pfizer CEO: Three Covid shots against omicron variant equivalent to two targeting original strains By CNBC Television


https://www.youtube.com/embed/0CIkR4b6JFs

Albert, it’s really great to see you. In this news. I think welcomed, by a lot of folks. Does this mean that three doses of your vaccine should potentially be enough to restore at least the antibody levels against Omicron. And maybe mean we won’t need to update the vaccine here is roughly. So in this study what we did and this is the first of many that were followed. It is a three doses of our vaccine against Omicron basically is equivalent to two doses of vaccine with the

A little strange. So, and as you remember, the original strain this antibody levels were translated with very, very high, efficacy of 95%. So these are good news on the two doses. The reduction was significant, but the third dose restored the the, those titles, very, very high.

What information are you expecting to get over the next couple weeks? Both from within, you know, finds her and by on Tech and also from around the world, we saw the South Africa day. Then last night. We know that academic Labs everywhere are working on this. How will you make that decision about whether those three doses are enough, or if you do need to switch to that Omicron specific vaccine, which we understand, you started working on already and could have by March.

Yeah, the data that we received our data, that we got from what we call pseudo virus, though. It’s not the real virus. It is a virus that we have constructed in our labs and it is identical with the American virus. This is a very well-known study. And the first day that are coming up from this. We are working to produce also reproduce the same results with the real virus, and that will come in maybe a week or two.

Those typically are more accurate because those studies are those essays are more sensitive. The ultimate proof is coming from Real World data. We need to see that. We are people that they have received three doses. People have received the two doses. If you have enough breakthrough, cases the severity of the cases, etc, etc. And that will come again. I think by the end of the month. So by the end of the month, for mystical, you have enough data to say, if Omicron, the solution will be just the third dose and they won’t

Monitor to see when the third goes wins or not or if we need to go we’ll specific against all migrants. Very embarrassing again based on the studies that we did because we didn’t test only the current vaccine against Doma current. We tested the some other vaccines that we have in our toolbox that are not commercially available, but they have been constructed just in case we are getting enough conclusions.

He believed that when if there is a need for a Nomicon future working, that should be a very good one. I think we should have a good chance to see if we need a non-conducting to have it in March to be very, very effective and that we will not lose any of our four billion and your capacity. We have to switch them on the convection. So that argument.

Hey Alberto, just to clarify things, all three of the shots, the two original shots. And then the booster shot. It’s the same formulation. It’s the same thing. Is it a combination of those three working together and somehow making it work better against the Omicron variant? Or is this just a situation where people who got the shot a while ago and then are boosted and updated. That’s, that’s what provides the effectiveness. And I’m trying to figure that out because there are people who have gotten their shots more recently and then there are kids ages 12.

Of the 17 who got their shots a while ago, but aren’t eligible for the booster yet. Where does that leave? All those categories of people? The best way to see it is the virus is the enemy want to protect ourselves to build a wall. The first dose builds a wall, but it is not very high. The second dose builds a wall on top of the first that it’s really high and now and it was very good for other variants. Now, it looks like the owner has the ability to jump over the visual, the third dose takes the wall, very high and suit,

Stop expect to stop the Army grunt. So people that they have two doses. They should get to the third one. But if they had two doses is very likely that you are better protected than if they don’t have any. Or they have only one because there are different elements of immune responses that the vaccines is created like the memory cells and those cells recognize spike in omikron that it is almost

Most 80 percent identical, so they should give against UV protection. That she gets abilities as a protection.

Shepard Smith here. Thanks for watching CNBC on YouTube.